![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
4 min
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
SARS-CoV-2 and dopamine neurons, valproate risks for men, neurologists on locum tenens Neurology Today in 5
-
- Medicine
Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the impact of SARS-CoV2 on dopamine neurons, a European Medicines Agency warning about valproate risks for men, and neurologists on the pros and cons of working locum tenens.
Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the impact of SARS-CoV2 on dopamine neurons, a European Medicines Agency warning about valproate risks for men, and neurologists on the pros and cons of working locum tenens.
4 min